The global pharmaceuticals and food anti-counterfeiting market is expected to reach USD 160.32 billion by 2020, according to a new study by Grand View Research, Inc. The rise in the consumption of counterfeit products and the implementation of strict regulations pertaining to anti-counterfeiting by the U.S. FDA are two of the primary growth drivers of this market. Moreover, anti-counterfeiting initiatives undertaken by manufacturers to curb revenue and brand image losses, the introduction of technological advancements such as ultra-high RFID tags and the high scale of counterfeiting in rapidly growing economies such as Brazil, India, China and Russia will serve this market as drivers.
http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting
No comments:
Post a Comment